For the quarter ending 2026-03-31, LQDA had $32,106K increase in cash & cash equivalents over the period. $50,160K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | 52,862 | 14,555 | -3,533 | -41,579 |
| Acquired in-process research and development | - | 2,000 | - | - |
| Stock-based compensation | 9,217 | 7,206 | 7,898 | 6,930 |
| Depreciation and amortization | 497 | 320 | 476 | 281 |
| Non-cash lease expense | -409 | 65 | 61 | 57 |
| Loss (gain) on disposal of property and equipment | - | -11 | - | - |
| Accretion and non-cash interest expense | 6,494 | 6,901 | 6,944 | 5,657 |
| Accounts receivable, net | 20,064 | 18,134 | 25,991 | 8,721 |
| Inventory | 4,565 | -943 | 17,951 | 4,872 |
| Prepaid expenses and other current assets | 2,780 | -3,904 | 2,981 | 898 |
| Other noncurrent assets | 4,601 | 4,217 | -13,466 | 6,878 |
| Accounts payable | 562 | -1,964 | -5,993 | 1,946 |
| Accrued expenses and other current liabilities | 14,532 | 32,753 | 17,922 | 8,681 |
| Operating lease liabilities | 372 | -99 | -88 | -85 |
| Other noncurrent liabilities | 873 | - | - | - |
| Net cash provided by (used in) operating activities | 52,990 | 44,244 | -9,770 | -39,481 |
| Purchase of in-process research and development | - | 2,000 | - | - |
| Purchases of property, plant and equipment | 2,830 | 2,038 | 911 | 1,057 |
| Net cash used in investing activities | -2,830 | -4,038 | -911 | -1,057 |
| Proceeds from long-term debt, net of fees | 0 | 0 | 0 | 50,000 |
| Payments on long-term debt | 19,969 | 8,057 | 8,057 | 2,854 |
| Principal payments on finance leases | 0 | 0 | 0 | 0 |
| Receipts from litigation financing | 163 | 100 | 314 | 435 |
| Proceeds from issuance of common stock under stock incentive plans | 1,752 | 935 | 2,498 | 125 |
| Net cash provided by (used in) financing activities | -18,054 | -7,022 | -5,245 | 47,706 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 32,106 | 33,184 | -15,926 | 7,168 |
| Cash, cash equivalents, and restricted cash, beginning of period | 194,184 | 161,000 | 176,926 | 169,758 |
| Cash, cash equivalents, and restricted cash, end of period | 226,290 | 194,184 | 161,000 | 176,926 |
Liquidia Corp (LQDA)
Liquidia Corp (LQDA)